Michel E. Bertrand

17.2k citations

161 papers · 9.8k indexed · 3 hit papers · h-index 52

Impact in

Cardiology and Cardiovascular Medicine top 0.1%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management

Papers in

Cardiology and Cardiovascular Medicine 134
- Acute Myocardial Infarction Research 64
- Antiplatelet Therapy and Cardiovascular Diseases 34
- Blood Pressure and Hypertension Studies 24
- Atrial Fibrillation Management and Outcomes 20
Internal Medicine 15
- Venous Thromboembolism Diagnosis and Management 15

Co-authors: Christophe Bauters Jean‐Marc Lablanche Eugène McFadden Éric Van Belle Gregg W. Stone Philip Urban Hans‐Jürgen Rupprecht Anthony Gershlick
Journals: Journal of the American College of Cardiology (29 papers)The American Journal of Cardiology (27 papers)Circulation (25 papers)European Heart Journal (9 papers)American Heart Journal (8 papers)
Partner nations: France United States Netherlands

In The Last Decade

Michel E. Bertrand

160 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation 2002 · 646 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 European Heart Journal
2000 Circulation
1991 New England Journal of Medicine

Peers

Countries citing papers authored by Michel E. Bertrand

Since Specialization

Citations

This map shows the geographic impact of Michel E. Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel E. Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel E. Bertrand more than expected).

Fields of papers citing papers by Michel E. Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel E. Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel E. Bertrand. The network helps show where Michel E. Bertrand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michel E. Bertrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel E. Bertrand Line = papers co-authored together Michel E. Bertrand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Incidence and Impact of Totally Occluded Culprit Coronary Arteries in Patients Presenting With Non–ST-Segment Elevation Myocardial Infarction The American Journal of Cardiology ·Josephine Warren, Roxana Mehran, Jennifer Yu, Ke Xu, Michel E. Bertrand, David A. Cox, A. Michael Lincoff, Steven V. Manoukian, E. Magnus Ohman, Stuart Pocock, Harvey D. White, Gregg W. Stone	2014	22
2	Impact of Nonculprit Vessel Myocardial Perfusion on Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes JACC: Cardiovascular Interventions ·Alexandra J. Lansky, Vivian G. Ng, Stephanie Meller, Ke Xu, Martin Fahy, Frederick Feit, E. Magnus Ohman, Harvey D. White, Roxana Mehran, Michel E. Bertrand, Walter Desmet, Martial Hamon, Gregg W. Stone	2014	3
3	Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease — Results from EUROPA International Journal of Cardiology ·Joep van der Leeuw, Rohit M. Oemrawsingh, Yolanda van der Graaf, Jasper J. Brugts, Jaap W. Deckers, Michel E. Bertrand, Kim Fox, Roberto Ferrari, Willem J. Remme, Maarten L. Simoons, Eric Boersma, Frank L.J. Visseren	2014	8
4	Automated 3D Analysis of Pre-Procedural MDCT to Predict Annulus Plane Angulation and C-Arm Positioning JACC. Cardiovascular imaging ·Mariam Samim, Pieter R. Stella, Pierfrancesco Agostoni, Jolanda Kluin, Lamsu Kim, Ricardo P.J. Budde, Gertjan T. Sieswerda, Дмитро Володимирович Пясковський, Şeyma Zeyrek Kurtoğlu, Ahmed Elkalioubie, Françis Juthier, Anouar Belkacemi, Michel E. Bertrand, Pieter A. Doevendans, Éric Van Belle	2013	43
5	Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure European Heart Journal ·Fabrice Ivanés, Sophie Susen, Frédéric Mouquet, Pascal Pigny, 英次海老井, Karine Sautière, Jean‐Philippe Collet, Farzin Beygui, Bernadette Hennache, Pierre Vladimir Ennezat, Françis Juthier, Florence Richard, Jean Dallongeville, Vadim Vlasov, Pieter A. Doevendans, Brigitte Jude, Michel E. Bertrand, Gilles Montalescot, Éric Van Belle	2011	100
6	Impact of Bleeding on Mortality After Percutaneous Coronary Intervention JACC: Cardiovascular Interventions ·Roxana Mehran, Stuart Pocock, Eugenia Nikolsky, George Dangas, Tim Clayton, Bimmer E. Claessen, Adriano Caixeta, Frederick Feit, Steven V. Manoukian, Harvey D. White, Michel E. Bertrand, E. Magnus Ohman, Helen Parise, Alexandra J. Lansky, A. Michael Lincoff, Gregg W. Stone	2011	277
7	OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PRIOR CORONARY ARTERY BYPASS GRAFTING: ANALYSIS FROM THE ACUITY TRIAL Journal of the American College of Cardiology ·Eugenia Nikolsky, Roxana Mehran, E. Magnus Ohman, Michel E. Bertrand, A. Michael Lincoff, Jeffrey W. Moses, Ecaterina Cristea, Harvey D. White, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone	2010	4
8	Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study American Heart Journal ·Michel E. Bertrand, Roberto Ferrari, S. Stern, Maarten L. Simoons, J. W. Deckers, Kim Fox	2010	28
9	Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications Journal of the American College of Cardiology ·Eugenia Nikolsky, Gregg W. Stone, Ajay J. Kirtane, George Dangas, Alexandra J. Lansky, Brent McLaurin, A. Michael Lincoff, Frederick Feit, Jeffrey W. Moses, Martin Fahy, Steven V. Manoukian, Harvey D. White, E. Magnus Ohman, Michel E. Bertrand, David A. Cox, Roxana Mehran	2009	143
10	Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation European Heart Journal ·Michel E. Bertrand Hit paper breakdown →	2002	646
11	Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial The Lancet ·William E. Boden, Wiek H. van Gilst, Usuki Hirokazu, Ian R. Starkey, Marc Carlier, Desmond G. Julian, Anne Whitehead, Michel E. Bertrand, Jacques Col, Ole Lederballe Pedersen, Kong I. Lie, Wook-Sung Park, Kim Fox	2000	54
12	741-2 Full Antiplatelet Therapy without Anticoagulation After Coronary Stenting Journal of the American College of Cardiology ·Jean‐Marc Lablanche, Gilles Grollier, Nicolas Danchin, J Bonnet, Éric Van Belle, G. Caianiello, Michel E. Bertrand	1995	12
13	Recoil following wiktor stent implantation for restenotic lesions of coronary arteries Catheterization and Cardiovascular Diagnosis ·Peter de Jaegere, Patrick W. Serruys, Gerrit‐Anne van Es, Michel E. Bertrand, V. Wiegand, Kovalenko Av, CAIO MARQUES DE SOUSA, Jan Piessens, B Valeix, Gisbert Kober, Wolfgang Weiß, R. Uebis	1994	23
14	Angiographic predictors of recurrence of restenosis after Wiktor stent implantation in native coronary arteries The American Journal of Cardiology ·Vladislav Svitailo, Patrick W. Serruys, Michel E. Bertrand, V. Wiegand, Kovalenko Av, CAIO MARQUES DE SOUSA, Jan Piessens, B Valeix, Gisbert Kober, Roy Huijsmans, Wolfgang Rutsch, R. Uebis	1993	37
15	Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery The American Journal of Cardiology ·Peter P. de Jaegere, Patrick W. Serruys, Michel E. Bertrand, V. Wiegand, Gisbert Kober, Kovalenko Av, B Valeix, R. Uebis, Jan Piessens	1992	70
16	Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience — March 1986 to March 1990) The American Journal of Cardiology ·Bradley H. Strauss, Patrick W. Serruys, Michel E. Bertrand, Jean‐Luc Puel, Bernhard Meier, Jean‐Jácques Goy, Lukas Kappenberger, A F Rickards, Ulrich Sigwart	1992	80
17	Clinical characteristics and angiographie follow-up of patients undergoing early or late repeat dilation for a first restenosis Journal of the American College of Cardiology ·Christophe Bauters, Jean‐Marc Lablanche, Eugène McFadden, Fabrice Leroy, Michel E. Bertrand	1992	38
18	Multi-center registry of percutaneous coronary rotational ablation using the rotablator Journal of the American College of Cardiology ·Maurice Buchbinder, David C. Warth, Alena V. Churkina, Nadim M. Zacca, Robert Ginsburg, Michel E. Bertrand, Raimund Erbel, Martin B. Leon	1991	11
19	Long term risk/benefit of PTCA of infarct related vessel Journal of the American College of Cardiology ·B.A.E. van Hal, Antoine Gommeaux, Jean M. Lablanche, Christophe Bauters, Fabrice Leroy, Michel E. Bertrand	1991	2
20	Apolipoprotein B Immunochemical Heterogeneity in Dialysed Patients with Chronic Renal Failure and Patients with Coronary Artery Stenosis American Journal of Nephrology ·Richard Reade, WU Jing-le, C Cachera, Patrick Duriez, M Dracon, Jean‐Marie Bard, Catherine Fiévet, Michel E. Bertrand, A Tacquet, Jean‐Charles Fruchart	1989	4

About Michel E. Bertrand

Michel E. Bertrand is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Endocrinology, Diabetes and Metabolism, having authored 161 papers that have together received 9.8k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (69 papers), Acute Myocardial Infarction Research (64 papers), Cardiac Imaging and Diagnostics (62 papers), Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Blood Pressure and Hypertension Studies (24 papers), Atrial Fibrillation Management and Outcomes (20 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Hormonal Regulation and Hypertension (15 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.6k citations), Internal Medicine (1.2k citations), Surgery (5.4k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations) and Endocrinology, Diabetes and Metabolism (765 citations). Michel E. Bertrand has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Christophe Bauters, Jean‐Marc Lablanche, Eugène McFadden, Éric Van Belle, Gregg W. Stone, Philip Urban, Hans‐Jürgen Rupprecht, Anthony Gershlick, Harvey D. White and Roxana Mehran. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Cardiology, Circulation, European Heart Journal and American Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact